ASMB Market Cap History
Below is a table of the ASMB market cap history going back to 7/14/2014:

Date ASMB Market Cap
7/14/201433.92M
8/11/201460.12M
11/10/201487.84M
3/10/2015157.97M
5/5/2015211.28M
8/10/2015239.97M
11/5/2015159.17M
3/7/2016103.35M
5/5/201689.75M
8/5/2016103.70M
11/3/2016219.97M
2/24/2017363.62M
5/4/2017416.13M
8/3/2017387.40M
10/27/2017539.85M
3/5/20181.14B
5/2/2018923.14M
8/7/20181.07B
11/5/2018583.62M
2/25/2019552.96M
5/6/2019432.66M
7/31/2019321.40M
11/4/2019440.72M
3/2/2020624.11M
5/4/2020581.15M
8/3/2020758.29M

Also see: ASMB Shares Outstanding History
and ASMB YTD Return
ASMB Historical Market Cap:
+66.97% CAGR
ASMB Historical Market Cap: +66.97% CAGR

Mouse over chart for data details
7/14/2014 ...8/3/2020
Assembly Biosciences is a clinical-stage biotechnology company. Co. is developing two programs: a class of oral therapeutic candidates for the treatment of chronic hepatitis B virus (HBV) infection and a class of oral live microbial biotherapeutic candidates, which are designed to treat disorders related with the microbiome. Co.'s lead HBV core inhibitor product candidate is ABI-H0731. ABI-H2158, its second product candidate in the HBV Cure program. ABI-H3733 is Co.'s third product candidate in the HBV Cure program. Co. has started a clinical study of ABI-M201 to evaluate the safety and its effects on disease activity measures in patients with mildly to moderately active ulcerative colitis. We show 26 historical shares outstanding datapoints in our ASMB shares outstanding history coverage, used to compute ASMB market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ASMB market cap history over the course of time is important for investors interested in comparing ASMB's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ASMB versus a peer is one thing; comparing ASMB market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ASMB can fluctuate over the course of history. With this page we aim to empower investors researching ASMB by allowing them to research the ASMB market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ASMB:
ASMB SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Assembly Biosciences (ASMB) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ASNS Market Cap History
ATEC Market Cap History
ATHX Market Cap History
ATNX Market Cap History
ATOS Market Cap History
ATRA Market Cap History
ATRC Market Cap History
ATRI Market Cap History
ATRS Market Cap History
ATXI Market Cap History
More Healthcare companies »

 

ASMB Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.